Recruiting
Phase 1

Study of AV-1959D, an Amyloid Beta Vaccine

Sponsor:

Institute for Molecular Medicine

Code:

NCT05642429

Conditions

Alzheimer Disease

Eligibility Criteria

Sex: All

Age: 60 - 70+

Healthy Volunteers: Not accepted

Interventions

AV-1959D

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information